PDE4 inhibitors, pharmaceutical compositions, and therapeutic applications
US-12522612-B2 · Jan 13, 2026 · US
This page is not indexed by search engines while we improve data quality.
Erdman Paul E patents
Erdman Paul E is listed as an inventor on 59 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Erdman Paul E |
| Total patents | 59 |
| First publication | Dec 15, 2016 |
| Latest publication | Jan 13, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Quinazolines, pharmaceutical compositions, and therapeutic applications
US-12419962-B2 · Sep 23, 2025 · US
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2025186434-A1 · Jun 12, 2025 · US
Estrogen receptor degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024368121-A1 · Nov 7, 2024 · US
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024197888-A1 · Jun 20, 2024 · US
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024190885-A1 · Jun 13, 2024 · US
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024190883-A1 · Jun 13, 2024 · US
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024174643-A1 · May 30, 2024 · US
Pde4 degraders, pharmaceutical compositions, and therapeutic applications
US-2024124418-A1 · Apr 18, 2024 · US
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024025863-A1 · Jan 25, 2024 · US
Recent patents
Latest publications not already listed above.
Quinazolines, pharmaceutical compositions, and therapeutic applications
US-2023293702-A1 · Sep 21, 2023 · US
Pde4 inhibitors, pharmaceutical compositions, and therapeutic applications
US-2023071529-A1 · Mar 9, 2023 · US
Ras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2023002371-A1 · Jan 5, 2023 · US
Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applications
US-2022298172-A1 · Sep 22, 2022 · US
Aminoamide compounds
US-11400084-B2 · Aug 2, 2022 · US
Substituted isoindolinones
US-11352338-B2 · Jun 7, 2022 · US
Compounds targeting proteins, compositions, methods, and uses thereof
US-11345714-B2 · May 31, 2022 · US
Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applications
US-11345712-B2 · May 31, 2022 · US
Bifunctional compounds
US-2022153751-A1 · May 19, 2022 · US
Fused thiophene compounds
US-2022088025-A1 · Mar 24, 2022 · US
Bifunctional compounds
US-11236103-B2 · Feb 1, 2022 · US
Bicyclic compounds and methods of use
US-11236105-B2 · Feb 1, 2022 · US
Fused thiophene compounds
US-11191769-B2 · Dec 7, 2021 · US
Aminoamide compounds
US-2021145812-A1 · May 20, 2021 · US
Compounds targeting proteins, compositions, methods, and uses thereof
US-2021139500-A1 · May 13, 2021 · US
Aminoamide compounds
US-10905684-B2 · Feb 2, 2021 · US
Compounds targeting proteins, compositions, methods, and uses thereof
US-10889593-B2 · Jan 12, 2021 · US
Compounds targeting proteins, compositions, methods, and uses thereof
US-10857155-B2 · Dec 8, 2020 · US
Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applications
US-2020369679-A1 · Nov 26, 2020 · US
Substituted isoindolinones
US-10844039-B2 · Nov 24, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Biotheryx Inc | 59 |
| Bio Theryx Inc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 49 |
| C07D495/04 | 33 |
| A61P29/00 | 31 |
| A61K31/55 | 30 |
| A61P11/00 | 24 |